Demetrix logo

Demetrix Funding & Investors

Berkeley, CA

Demetrix manufactures natural medicines using synthesis biology. The company uses genetics and computing enabled deciphering technology to produce drugs. It enables refactoring biotechnology microbial hosts for gene synthesis. The company engineers strain to produce co-evolved and bio-inspired medicines and nutraceuticals. The company was founded in 2015 and is headquartered in Emeryville, California.

demetrixbio.com

Total Amount Raised: $61,000,000

Demetrix Funding Rounds

  • Series A

    $50,000,000

    Series A Investors

    Horizons Ventures
    Tuatara Capital
    Berkeley Catalyst Fund
  • Seed

    $11,000,000

    Seed Investors

    Horizons Ventures
Funding info provided by Diffbot.